Safety and effectiveness of ustekinumab for treatment of moderate to severe psoriasis: a prospective study in a clinical setting.

@article{MolinaLeyva2014SafetyAE,
  title={Safety and effectiveness of ustekinumab for treatment of moderate to severe psoriasis: a prospective study in a clinical setting.},
  author={Alejandro Molina-Leyva and H Husein-ElAhmed and Ram{\'o}n Naranjo-Sintes and Jos{\'e} Carlos Ruiz-Carrascosa},
  journal={Journal of drugs in dermatology : JDD},
  year={2014},
  volume={13 8},
  pages={
          971-4
        }
}
BACKGROUND There are few studies analyzing the behavior of ustekinumab in the complex management of psoriasis within diary clinical practice setting. OBJECTIVE To assess the utility of ustekinumab in a psoriasis unit. METHODS Analysis of the prospective data gathered during the follow-up of 30 consecutive psoriasis patients treated with ustekinumab at a single referral centre. Three effectiveness endpoints were defined 12 weeks, 28 and "long-term treatment". The main outcome measure was… CONTINUE READING